Načítá se...

The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations

For patients with epidermal growth factor receptor (EGFR) mutation-positive lung cancer, the relationship between the dose or duration of treatment with tyrosine kinase inhibitor (TKI) and overall survival remains unclear. Here, we analyzed clinical data of 39 patients who were diagnosed with EGFR m...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Suzuki, Hidekazu, Hirashima, Tomonori, Okamoto, Norio, Yamadori, Tadahiro, Tamiya, Motohiro, Morishita, Naoko, Shiroyama, Takayuki, Otsuka, Tomoyuki, Kitai, Kanako, Kawase, Ichiro
Médium: Artigo
Jazyk:Inglês
Vydáno: Sun Yat-sen University Cancer Center 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3845597/
https://ncbi.nlm.nih.gov/pubmed/23237215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.012.10160
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!